Hospital Universitario De Burgos — Clinical Trial Site

81 Registered trials

39 Currently recruiting

Organisation

Hospital Universitario De Burgos

Location

Burgos, Spain

Identifier

ORG-100047051

Address

Avenida De Las Islas Baleares 3, 09006, Spain

Departments

1315: Hematología
172422: Hematology and Transfusion Medicine
Allergology
Allergy
Cardiology
Clinical Haematology
Dialysis Unit
Gastroenterology
Hematología
Hematology
Hematology and Hematherapy
Hematology and Hemotherapy
infectious diseases
Intensive Care
Medical oncology
Nefrología
Neumología
Neurología
Neurology
Obstetrician and Gynecologist
Oncología
Oncología Médica
Oncology
Oncology Service
Ophthalmology
Pediatrics
Pneumology
Psiquiatría
Research Unit
Servicio de digestivo
Servicio de Neurología
Servicio de Oncología
Servicio Oncologia Medica

Clinical trials at this site (81)

Search interface

Trial of Trastuzumab Deruxtecan in Combination with Pembrolizumab Versus Pembrolizumab with Platinum-based Chemotherapy in First-line HER2 o… Recruiting

2024-515658-26-00 Unresectable or Metastatic HER2 overexpressing and PD-L 5 2026-01-21
A study to find how well budoprutug (TNT119) works and how safe it is in participants with immune thrombocytopenia Recruiting

2024-519745-30-01 Immune Thrombocytopenia (ITP) 9 2025-12-19
A Follow-up Study of Mezagitamab in Adults with Chronic Primary Immune Thrombocytopenia Recruiting

2025-521692-31-00 Chronic Primary Immune Thrombocytopenia 5 2025-12-19
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic … Recruiting

2025-522860-34-00 Chronic lymphocytic leukemia (CLL) 5 2025-12-16
A study to evaluate acalabrutinib, in combination with the R-CHOP standard of care, for previously untreated mantle cell lymphoma in Spain. Recruiting

2025-521152-34-00 mantle cell lymphoma (MCL) 4 2025-09-04
Safety, Tolerability, and Efficacy of NVG-2089 in Participants with Immune Thrombocytopenia Recruiting

2024-520359-26-00 Immune Thrombocytopenia (ITP) 4 2025-08-20
Response-adaptive to Epcoritamab In FIrst Relapse: A Phase II, response-adaptive, Open-Label, Multicenter Study to Evaluate the Efficacy of … Recruiting

2024-514440-86-00 Relapse/Refractory Large B Cell Lymphoma 4 2025-08-04
A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esoph… Recruiting

2023-509630-19-00 Esophageal Squamous Cell Carcinoma (ESCC) 5 2025-07-31
A Phase 3 Study Comparing BMS-986365 versus Investigator’s Choice of Therapy in Participants with Metastatic Castration-resistant Prostate C… Recruiting

2024-517422-25-00 Metastatic Castration-resistant Prostate Cancer (mCRPC) 5 2025-05-22
Phase II, single arm, multicentre clinical trial to evaluate the activity of encorafenib plus binimetinib followed by Cemiplimab And Fianlim… Recruiting

2024-513375-40-00 Melanoma 4 2025-05-16
Lu177-Dotatate every 16 weeks to reduce adverse events in patients with midgut neuroendocrine tumors Recruiting

2024-517921-14-00 Neuroendocrine tumors of midgut origin 9 2025-05-07
A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinoph… Recruiting

2024-515162-13-00 Eosinophilic Asthma 5 2025-04-29
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) versus Conventional Treatment in Acute Myocarditis: INFLAMA study Recruiting

2024-513803-15-00 Acute myocarditis 6 2025-01-30
ANALYSIS OF EFFECTIVENESS OF NEOADJUVANT CHEMOTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED COLON CANCER. Recruiting

2024-519825-39-00 Locally advanced colon cancer (LACC) 4 2025-01-30
A Randomized Clinical Trial, Multicentre, Open-label, Parallel-group, to define the best Strategy for the management of hEart failure aNd ch… Recruiting

2024-513971-42-00 Chronic heart failure (NYHA I-III) and non-dialysis CKD 5 2024-10-01
Study evaluating whether giving 177Lu-PSMA-617 to men having a spreading prostate cancer which does not respond well to the current standard… Recruiting

2022-502408-57-00 Novo metastatic hormone-sensitive prostate cancer (mHSP 5 2024-09-04
Registry-based randomized trial to determine the role of Oxygen in acute Pulmonary Embolism Recruiting

2024-511959-18-01 Acute Pulmonary Embolism 5 2024-07-01
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo i… Recruiting

2024-510959-35-00 Parkinson's disease 4 2023-09-07
A Study to Evaluate the Efficacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis (ELIXIR) Recruiting

2024-513562-19-00 End-Stage Kidney Disease 5 2023-08-30
A Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLU… Recruiting

2023-507372-42-00 Schizophrenia 4 2021-09-20
Clinical trial to asses the efficacy and safety of a vaccine for grasses and cupressaceae allergy Recruiting

2024-514524-16-00 Aetiological treatment of moderate-severe intermitent o 5 2021-05-11
Radiation-Free Therapy for the Initial treatment of Good prognosis early non-bulky HL, defined by a low Metabolic Tumor Volume and a negativ… Recruiting

2024-515063-66-00 Early stage classical Hodgkin Lymphoma (cHL) without bu 4 2021-03-30
LONG-TERM FOLLOW-UP STUDY OF EARLY STAGE BREAST CANCER PATIENTS INCLUDED IN GEICAM STUDIES Recruiting

2022-502706-33-00 Patients with invasive breast cancer in early stages 6 2018-01-10